0001610717-24-000232.txt : 20240507
0001610717-24-000232.hdr.sgml : 20240507
20240507170634
ACCESSION NUMBER: 0001610717-24-000232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240507
DATE AS OF CHANGE: 20240507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones William Benton
CENTRAL INDEX KEY: 0001664506
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 24923090
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD, SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
form4.xml
X0508
4
2024-05-06
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001664506
Jones William Benton
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
true
See Remarks
false
Common Stock
2024-05-06
4
P
0
20000
1.7312
A
153773
D
Warrant (Right to Buy)
3.5
2024-05-06
4
P
0
19357
A
2024-05-06
2025-06-30
Common Stock
19357
19357
D
Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.
SVP, Pharmaceutical Development
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
2024-05-07